Melanoma
Clinical practice guidelines for the diagnosis and management of melanoma
Australia and New Zealand have the highest incidence of melanoma in the world, and comprehensive, up-to-date, evidence-based national guidelines for its management are therefore of great importance. Both countries have populations of predominantly Celtic origin, and in the course of day-to-day and recreational activities their citizens are inevitably subjected to high levels of solar UV exposure. These two factors are considered to be predominantly responsible for the very high incidence of melanoma (and other forms of skin cancer) in the two nations. In Australia melanoma is the third most common cancer in men and the fourth most common in women, with over 13,000 new cases and over 1,750 deaths each year. [1]
Clinical practice guidelines for the diagnosis and management of melanoma
*Note: If you experience difficulty accessing this guideline please contact us on guidelines@cancer.org.au
Public Consultation
Melanoma Institute Australia and Cancer Council Australia are conducting a review of the clinical practice guidelines for the diagnosis and management of melanoma.
The Guidelines Working Party is revising the guidelines in stages and anticipates seeking public comment on all chapters over time.
As part of this process, the first 6 chapters have now completed a 6-week public consultation period, with feedback received now being considered.
Further chapters will be made available for public consultation on 15 July 2025.
